An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. "These findings support ...
Feb 10, 2026
0
42
For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, ...
Sep 6, 2024
0
23
Artificial intelligence (AI) could be around twice as accurate as a biopsy at grading the aggressiveness of some sarcomas, according to new research from The Royal Marsden NHS Foundation Trust and The Institute of Cancer ...
Nov 1, 2023
0
44
Leiomyosarcoma is a type of soft tissue sarcoma that is hard to treat and associated with a poor prognosis. Scientists at the Institute of Cancer Research are working to better understand the biology of this cancer to develop ...
Jul 25, 2023
0
48
